Chi-LiVita SRL
Chi-LiVita reported total assets of 340,234 € at the end of the 2025 financial year (annual accounts filed with the NBB on 07 Oct 2026).
The score of Chi-LiVita shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +229 % Total assets +147 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Chi-LiVita's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Oct 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 19 Jul 2024
Chi-LiVita's financial analysis
- Solvency68.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Chi-LiVita
Chi-LiVita's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0791.165.256
- VAT number
- BE0791165256
- Peppol
- Registered · 0208:0791165256 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Sep 2022
- Registered office
- 2870 Puurs-Sint-Amands
- Latest accounts
- 2025 · filed on 07 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Chi-LiVita (SRL) has been based in Puurs-Sint-Amands since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 110,175 € and equity of 233,971 €; its revenue is not published. Its solvency stands at 68.8%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Chi-LiVita
Companies in the same business, of comparable size and area, outside its group.
- Maxkorp Business and other management consultancy activities Ghent · balance sheet 752,596 €
- North Flow Retail sale of pharmaceutical products Antwerp · balance sheet 303,640 €
- Lidefarma Retail sale of pharmaceutical products Lierde · balance sheet 495,027 €
- KG Farma Retail sale of pharmaceutical products Leuven · balance sheet 622,811 €
- Vroome Pharma Management Retail sale of pharmaceutical products Antwerp · balance sheet 229,894 €
- JPMA Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet 295,815 €
- Pharmacie de Rienne Retail sale of pharmaceutical products Gembloux · balance sheet 334,259 €
- Futurophar Retail sale of pharmaceutical products Ghent · balance sheet 394,606 €
Frequently asked questions about Chi-LiVita
What is the revenue of Chi-LiVita?
Chi-LiVita files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Chi-LiVita?
In Belgium, the VAT number is the company number prefixed with BE: BE0791165256 for Chi-LiVita, if the company is VAT-registered. Its company number (CBE) is 0791.165.256.
Where is the registered office of Chi-LiVita?
According to the CBE register, the registered office of Chi-LiVita is in 2870 Puurs-Sint-Amands.
What is the equity of Chi-LiVita?
At the close of the 2025 financial year, the equity of Chi-LiVita amounts to 233,971 €, a solvency of 68.8% of total assets.
Who manages Chi-LiVita?
The register lists 1 active mandates at Chi-LiVita. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Chi-LiVita
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →